Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and Secnidazole

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a multi-centered, randomized, open-label, parallel, phase IV clinical trial comparing the effectiveness and cost-effectiveness of oral multi-dose metronidazole (MTZ) and oral single-dose secnidazole (SEC) for the treatment of Trichomonas vaginalis in both women and men.
Epistemonikos ID: 45d397d2fd239b1840e9afbff712e6c965f82b9a
First added on: May 15, 2024